Literature DB >> 18056165

The dynamics of estrogen receptor status in breast cancer: re-shaping the paradigm.

Sara Lopez-Tarruella1, Rachel Schiff.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18056165     DOI： 10.1158/1078-0432.CCR-07-1399

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


× No keyword cloud information.
  22 in total

Review 1.  Mechanisms of aromatase inhibitor resistance.

Authors:  Cynthia X Ma; Tomás Reinert; Izabela Chmielewska; Matthew J Ellis
Journal:  Nat Rev Cancer       Date:  2015-05       Impact factor: 60.716

2.  Hedgehog signaling is a novel therapeutic target in tamoxifen-resistant breast cancer aberrantly activated by PI3K/AKT pathway.

Authors:  Bhuvaneswari Ramaswamy; Yuanzhi Lu; Kun-Yu Teng; Gerard Nuovo; Xiaobai Li; Charles L Shapiro; Sarmila Majumder
Journal:  Cancer Res       Date:  2012-08-08       Impact factor: 12.701

Review 3.  Biology and therapeutic potential of PI3K signaling in ER+/HER2-negative breast cancer.

Authors:  Xiaoyong Fu; C Kent Osborne; Rachel Schiff
Journal:  Breast       Date:  2013-09-05       Impact factor: 4.380

Review 4.  HER2: biology, detection, and clinical implications.

Authors:  Carolina Gutierrez; Rachel Schiff
Journal:  Arch Pathol Lab Med       Date:  2011-01       Impact factor: 5.534

5.  Hypoxia differentially regulates estrogen receptor alpha in 2D and 3D culture formats.

Authors:  Nathan A Whitman; Zhi-Wei Lin; Rachael M Kenney; Leonardo Albertini; Matthew R Lockett
Journal:  Arch Biochem Biophys       Date:  2019-06-01       Impact factor: 4.013

6.  Gefitinib or placebo in combination with tamoxifen in patients with hormone receptor-positive metastatic breast cancer: a randomized phase II study.

Authors:  C Kent Osborne; Patrick Neven; Luc Y Dirix; John R Mackey; Jean Robert; Craig Underhill; Rachel Schiff; Carolina Gutierrez; Ilenia Migliaccio; Valsamo K Anagnostou; David L Rimm; Patrick Magill; Mark Sellers
Journal:  Clin Cancer Res       Date:  2011-01-10       Impact factor: 12.531

Review 7.  Mechanisms of endocrine resistance in breast cancer.

Authors:  C Kent Osborne; Rachel Schiff
Journal:  Annu Rev Med       Date:  2011       Impact factor: 13.739

8.  Estrogen receptors similarly mediate the effects of 17β-estradiol on cellular responses but differ in their potencies.

Authors:  Yanfang Huang; Xiaodong Li; Mesut Muyan
Journal:  Endocrine       Date:  2010-11-11       Impact factor: 3.633

9.  Proteomic and transcriptomic profiling reveals a link between the PI3K pathway and lower estrogen-receptor (ER) levels and activity in ER+ breast cancer.

Authors:  Chad J Creighton; Xiaoyong Fu; Bryan T Hennessy; Angelo J Casa; Yiqun Zhang; Ana Maria Gonzalez-Angulo; Ana Lluch; Joe W Gray; Powell H Brown; Susan G Hilsenbeck; C Kent Osborne; Gordon B Mills; Adrian V Lee; Rachel Schiff
Journal:  Breast Cancer Res       Date:  2010-06-22       Impact factor: 6.466

10.  History, biology, and health inequities: emergent embodied phenotypes and the illustrative case of the breast cancer estrogen receptor.

Authors:  Nancy Krieger
Journal:  Am J Public Health       Date:  2012-11-15       Impact factor: 9.308
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.